Person

Cécile Ronckers

Dr. Ronckers
Title:Dr.
Current position:Scientific personnel
Specialist field:Biometrie und Registerforschung
Office address:

Institut für Biometrie und Registerforschung
Fehrbelliner Straße 38
16816 Neuruppin

Office phone number:+49 3391 39 14590
Office email:cecile.ronckers@mhb-fontane.de
 
Curriculum Vitae

Dr. Cécile Ronckers holds a Master’s Degree in Health Sciences (Maastricht University, 1995) and a PhD in Epidemiology (Vrije Universiteit Amsterdam, 2001). Further training and research experience in risk modelling, radiation sciences, cancer epidemiology, and survivorship studies was obtained at the U.S. National Cancer Institute (1999-2006). She continued survivorship research at the Emma Children’s Hospital/AMC Amsterdam, embedded in the national LATER Study Group. In 2018 her ongoing research line on subsequent tumors and radiotherapy-related side effects was integrated into the new Princess Máxima Center for Pediatric Oncology in Utrecht (The Netherlands). She is an active member of trans-Atlantic consortia (PENTEC, IGHG) to summarize and translate scientific evidence into recommendations for care, and she serves as Board Member of the European PanCare Consortium. In 2019, she joined the Brandenburg Medical School in a dual position as Project Coordinator for a project about various aspects of second opinion procedures in the German health care system from patients’ and physicians’ perspectives (ZWEIT), and as Senior Researcher in the Institute for Biostatistics and Registry Research. For a complete CV, click here.

Publications

Kok JL, Teepen JC, van der Pal HJ, van Leeuwen FE, Tissing WJE, Neggers SJCMM, Loonen JJ, Louwerens M, Versluys B, Van den Heuvel-Eibrink MM, Van Dulmen-den Broeder E, Jaspers MMW, Van Santen HM, Van der Heiden-van der Loo M, Janssens GO, Maduro JH, Bruggink AH, Jongmans MC, Kremer LCM, Ronckers CM; DCOG-LATER Study Group. Histologically confirmed solid benign tumors among long-term childhood cancer survivors: A DCOG LATER record linkage study. JAMA Oncology. In press.

Teepen JC, Kremer LC, Van der Heiden-van der Loo M, Tissing WJ, Van der Pal HJ, Van den Heuvel-Eibrink MM, Loonen JJ, Louwerens M, Versluys B, Van Dulmen-den Broeder E, Visser O, Maduro JH, Van Leeuwen FE, Ronckers CM; DCOG-LATER Study Group. Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort. Cancer Causes Control. In press.

Allodji RS, Hawkins MM, Bright CJ, Fidler-Benaoudia MM, Winter DL, Alessi D, Fresneau B, Journy N, Morsellino V, Bárdi E, Bautz A, Byrne J, Feijen ELA, Teepen JC, Vu-Bezin G, Rubino C, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Hau EM, Jankovic M, Kaatsch P, Kaiser M, Linge H, Muraca M, Llanas D, Veres C, Øfstaas H, Diallo I, Mansouri I, Ronckers CM, Skinner R, Terenziani M, Wesenberg F, Wiebe T, Sacerdote C, Jakab Z, Haupt R, Lähteenmäki P, Zaletel LZ, Kuehni CE, Winther JF, Michel G, Kremer LCM, Hjorth L, Haddy N, De Vathaire F, Reulen RC. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup. Eur J Cancer. In press.

Streefkerk N, Heins MJ, Teepen JC, Feijen EAM, Bresters D, Van Dulmen-den Broeder E, Van der Heiden-van der Loo M, Van den Heuvel-Eibrink MM, Van Leeuwen FE, Loonen JJ, Van der Pal HJH, Ronckers CM, Versluys AB, Tissing WJE, Korevaar JC, Kremer LCM; DCOG-LATER Study Group. The involvement of primary care physicians in care for childhood cancer survivors. Pediatr Blood Cancer. In press.

Teepen JC, Kok JL, Kremer LC, Tissing WJE, Van den Heuvel M, Loonen JJ, Bresters D, Van der Pal HJ, Versluys AB, Van Dulmen den Broeder E, Nijsten T, Hauptmann M, Holllema N, Dolsma W, Van Leeuwen FE, Ronckers CM, for the DCOG LATER Study Group. Long-term risk of skin cancer among childhood cancer survivors: a DCOG-LATER cohort study. J Natl Cancer Inst. In press.

Kok JL*, Teepen JC*, Van Leeuwen FE, Tissing WJE, Neggers, SJCMM, Van der Pal HJ, Loonen JJ, Bresters D, Versluys AB, Van den Heuvel-Eibrink MM, Van Dulmen-den Broeder, Van der Heiden-van der Loo, Aleman BMP, Daniels L, Haasbeek CJA, Hoeben B, Janssens GO, Maduro JH, Oldenburger O, Van Rij C, Tersteeg RJHA, Hauptmann M, Kremer LCM, Ronckers CM, for the DCOGLATER Study Group. Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age. Neuro Oncology. In press.

Vaarwerk B, Schoot RA, Maurice-Stam H, Slater O, Hartley B, Saeed P, Gajdosova E, Van den Brekel MW, Balm AJM, Hol MLF, Van Jaarsveld S, Kremer LCM, Ronckers CM, Mandeville HC, Pieters BR, Gaze MN, Davila Fajardo R, Strackee SD, Dunaway D, Smeele LE, Chisholm JC, Caron HN, Grootenhuis MA, Merks JHM. Psychosocial well-being of long-term survivors of pediatric head-neck rhabdomyosarcoma. Pediatr Blood Cancer. In press.

Teepen JC, Curtis RE, Dores GM, Berrington de Gonzalez MM, Van den Heuvel Eibrink MM, Kremer LCM, Gilbert ES, Van Leeuwen FE, Ronckers CM, Morton LM. Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2011. Leukemia. In press.

Grabow D, Kaiser M, Hjorth L, Byrne J, Ronckers CM, Kaatsch P. on behalf of the PanCareSurFup Consortium The PanCareSurFup cohort of 83,333 5-year survivors of childhood cancer - Methodology and results of harmonising data to establish a cohort from 12 European countries. Eur J Epidemiol. In press.

Van den Berg MH*, Overbeek A*, Lambalk CB, Kaspers GJL, Bresters D, Van den Heuvel-Eibrink MM, Kremer LC, Loonen JJ, Van der Pal HJ, Ronckers CM, Tissing WJE, Versluys AB, Van der Heiden-van der Loo M, Heijboer AC, Hauptmann M, Twisk JWR, Laven JSE, Beerendonk CCM, Van Leeuwen FE, Van Dulmen-den Broeder E; DCOG LATER-VEVO study group. Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve. Hum Reprod. In press.

Virgolin M, Van Dijk IWM, Wiersma J, Ronckers CM, Witteveen C, Bel A, Alderliesten T, Bosman P. On the feasibility of automatically selecting similar patients in highly individualized radiotherapy dose reconstruction for historic data of paediatric cancer survivors. Med Phys. In press.

Wang Z, Balgobind BV, Virgolin M, Van Dijk IWEM, Wiersma J, Ronckers CM, Bosman PAN, Bel A, Alderliesten T. How do patient characteristics and anatomical features correlate to accuracy of organ dose reconstruction for Wilms' tumor radiation treatment plans when using a surrogate patient's CT scan? J Radiol Prot. 2019; 39(2): 598-619.

Feijen EAML, Font-Gonzalez A, Van der Pal HJH, Kok WEM, Geskus RB, Ronckers CM, Bresters D, Van Dalen EC, Van Dulmen-den Broeder E, Van den Berg MH, Van der Heiden-Van der Loo M, Van den Heuvel-Eibrink MM, Van Leeuwen FE, Loonen JJ, Neggers SJCMM, Versluys ABB, Tissing WJE, Kremer LCM; DCOG-LATER Study Group.Risk and Temporal Changes of Heart Failure Among 5-Year Childhood Cancer Survivors: a DCOG-LATER Study. J Am Heart Assoc. 2019; 8(1): e009122.

Feijen EAM, Font-Gonzalez A, Van der Pal HJH, Kok WEM, Geskus RB, Ronckers CM, Bresters D, Van Dalen EC, Van Dulmen-den Broeder E, Van den Berg MH, Van der Heiden-van der Loo M, Van den Heuvel-Eibrink MM, Van Leeuwen FE, Loonen JJ, Neggers SJCMM, Versluys AB, Tissing WJE, Kremer LCM, on behalf of the DCOG LATER Study Group. Risk and temporal changes of heart failure among 5-year childhood cancer survivors: a DCOG-LATER study. J Am Heart Assoc. 2019; 8(1): e009122.

Van de Loo LEXM, Van den Berg MH, Overbeek A, Van Dijk M, Damen L, Lambalk CB, Ronckers CM, Van den Heuvel-Eibrink MM, Kremer LCM, Van der Pal HJ, Laven JSE, Tissing WJE, Loonen JJ, Versluys B, Bresters D, Kaspers GJL, Van Leeuwen FE, Van Dulmenden Broeder E; DCOG LATER-VEVO Study Group. Uterine function, pregnancy complications, and pregnancy outcomes among female childhood cancer survivors. Fertil Steril. 2019; 111(2): 372-380.

Meulepas J, Ronckers CM, Smets AMJB, Nievelstein RAJ, Gradowska P, Lee C, Jahnen A, Van Straten M, Klein MW, Merks JH, Visser O, van Leeuwen FE, Hauptmann M. Radiation exposure from pediatric CT scans and subsequent cancer risk in the Netherlands. J Natl Cancer Inst. 2019; 111: 256-263.

Teepen JC*, Kok JL*, Van Leeuwen FE, Tissing WJ, Dolsma WV, Van der Pal HJ, Van den Heuvel-Eibrink MM, HJ van der Pal, Loonen JJ, Bresters D, Versluys B, Van den Heuvel-Eibrink MM, Neggers SJCMM, Van Dulmen-den Broeder E, Van den Berg H, Van der Heiden-van der Loo M, Hauptmann M, Jongmans MC, Overbeek LI, Van de Vijver MJ, Kremer LCM, Ronckers CM and the DCOG LATER Study Group. Colorectal adenomas and cancers after childhood cancer treatment: a DCOG-LATER record linkage study. J Natl Cancer Inst. 2018; 110(7): 758-767.

Haupt R, Essiaf S, Dellacasa C, Ronckers CM, Schrappe M, Hjorth L, Ladenstein R. PancareSurFup, ENCAA, ExPo-r-net Working Groups. The ‘Survivorship Passport’ for Childhood Cancer Survivors. Eur J Cancer. 2018; 102: 69-81.

Bright CJ, Hawkins MM, Winter DL, Alessi D, Allodji RS, Bagnasco F, Bárdi E, Bautz A, Byrne J, Feijen EAM, Fidler MM, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Haddy N, Jankovic M, Kaatsch P, Kaiser M, Kuehni CE, Linge H, Øfstaas H, Ronckers CM, Skinner R, Teepen JC, Terenziani M, Vu-Bezin G, Wesenberg F, Wiebe T, Sacerdote C, Jakab Z, Haupt R, Lähteenmäki P, Zaletel LZ, Kuonen R, Winther JF, De Vathaire F, Kremer LC, Hjorth L, Reulen RC; PanCareSurFup Consortium. Risk of soft-tissue sarcoma among 69,460 5-year survivors of childhood cancer in Europe. J Natl Cancer Inst. 2018; 110(6): 649-660.

Wang Z, Van Dijk I, Wiersma J, Ronckers CM, Oldenburger F, Balgobind B, Bosman P, Bel A, Alderliesten T. Are age- and gendermatched childhood cancer patients' CT scans suitable for 2D-to-3D dose reconstruction. Med Phys. 2018; 45(6): 2628-2638.

Chow EJ, Chen Y, Hudson MM, Feijen EAM, Kremer LC, Ronckers CM, Robison LL, Armstrong GT, Yasui Y. Prediction of ischemic heart disease and stroke among childhood cancer survivors. J Clin Oncol. 2018; 36(1): 44-52.

Fidler MM, Reulen RC, Winter DL, Allodji RS, Bagnasco F, Bárdi E, Bautz A, Bright CJ, Byrne J, Feijen EAM, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Haddy N, Jankovic M, Kaatsch P, Kaiser M, Kuonen R, Linge H, Maule M, Merletti F, Øfstaas H, Ronckers CM, Skinner R, Teepen J, Terenziani M, Vu-Bezin G, Wesenberg F, Wiebe T, Jakab Z, Haupt R, Lähteenmäki P, Zaletel LZ, Kuehni CE, Winther JF, De Vathaire F, Kremer LC, Hjorth L, Hawkins MM. Risk of subsequent primary bone cancers among 69,460 5-year survivors of childhood and adolescent cancer diagnosed throughout Europe. J Natl Cancer Inst. 2018; 110(2).

Klein Hesselink M, Bocca G, Hummel Y, Brouwers A, Burgerhof J, Van Dam E, Gietema J, Havekes B, Van den Heuvel- Eibrink M, Corssmit E, Kremer L, Netea-Maier R, Van der Pal H, Peeters R, Plukker, Ronckers CM, Santen HM, Van der Meer P, Links T, Tissing W. Diastolic dysfunction is common in survivors of pediatric differentiated thyroid carcinoma. Thyroid. 2017; 27: 1481-1489.

Teepen JC, Van Leeuwen FE, Tissing WJ, Van Dulmen-den Broeder E, Van den Heuvel-Eibrink MM, HJ van der Pal, Loonen JJ, Bresters D, Versluys B, Neggers SJCMM, Jaspers MW, Hauptmann M, Van der Heiden-van der Loo M, Visser O, Kremer LCM, Ronckers CM. on behalf of the DCOG LATER Study Group. Long-term risk of subsequent malignant neoplasms after treatment for childhood cancer in the DCOG LATER Study Cohort: Role of Chemotherapy. J Clin Oncol. 2017; 35: 2288-2298.

Moskowitz Ch, Chou JF, Sklar CA, Barnea D, Ronckers CM, Novetsky Friedman D, Neglia JP, Turcotte L, Howell R, Henderon TO, Armstrong GT, Leisenring WM, Robison LL, Van Leeuwen FE, Pike M, Oeffinger K. Radiation-Associated Breast Cancer and Gonadal Hormone Exposure: A Report from the Childhood Cancer Survivor Study. Br J Cancer. 2017; 117: 290-299.

Nies M, Klein Hesselink MS, Huizinga GA, Sulkers S, Brouwers AH, Burgerhof JGM, Van Dam EWCM, Havekes B, Van den Heuvel-Eibrink MM, Corssmit EPM, Kremer LCM, Netea-Maier RT, Van der Pal HJH, Peeters RP, Plukker JTM, Ronckers CM, Van Santen HM, Tissing WJE, Links TP, Bocca G. Long-term quality of life in adult survivors of pediatric differentiated thyroid carcinoma. J Clin Endocrinol Metabol. 2016; 102: 1218-1226.

Meulepas JM, Smets AM, Nievelstein RA, Gradowska P, Verbeke J, Holscher HC, Rutten MJ, Kieft M, Ronckers CM, Hauptmann M. Trends and patterns of computed tomography scan use among children in the Netherlands: 1990-2012. Eur Radiol. 2017; 27: 2426-2433.

Klein Hesselink MS, Nies M, Bocca G, Brouwers AH, Burgerhof JG, Van Dam EW, Havekes B, Van den Heuvel-Eibrink MM, Corssmit EP, Kremer LC, Netea-Maier RT, Van der Pal HJ, Peeters RP, Schmid KW, Smit JW, Williams GR, Plukker JT, Ronckers CM, Van Santen HM, Tissing WJ, Links TP. Pediatric differentiated thyroid carcinoma in the Netherlands: a nationwide followup study. J Clin Endocrinol Metab. 2016; 101: 2031-9.

Van Dijk IWEM, Van der Pal JHJ, Van Os RM, Roos YBWEM, Sieswerda E, Van Dalen EC, Ronckers CM, Oldenburger F, Van

Leeuwen FE, Caron HN, Koning CCE, Kremer LCM. High risk of symptomatic stroke 25 years after radiotherapy for childhood cancer: a cohort analysis. Int J Radiat Oncol Biol Phys. 2016; 96: 597-605.

Clement SC, Schoot RA, Slater O, Chisholm JC, Abela C, Balm AJM, Van den Brekel MW, Breunis WB, Chang YC, Davila Fajardo R, Dunaway D, Gajdosova E, Gaze MN, Gupta S, Hartley B, Kremer LCM, van Lennep M, Levitt GA, Mandeville HC, Pieters BR, Saeed P, Smeele LE, Strackee SD, Ronckers CM, Caron HN, Van Santen HM, Merks JHM. Endocrine disorders among survivors of childhood head and neck rhabdomyosarcoma. Eur J Cancer. 2016; 54: 1-10.

Meulepas JM, Ronckers CM, Merks J, Weijerman ME, Lubin JH, Hauptmann M. Confounding of the association between radiation exposure from CT scans and risk of leukemia and brain tumors by cancer susceptibility syndromes. J Radiol Prot. 2016; 36: 953-974.

Clement SC, Peeters RP, Ronckers CM, Links TP, Van den Heuvel-Eibrink MM, Nieveen van Dijkum EJ, Van Rijn RR, Van der Pal HJ, Neggers SJ, Kremer LC, van Eck-Smit BL, Van Santen HM. Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma - A systematic review. Cancer Treat Rev. 2015; 41: 925-34.

Schoot RA, Slater O, Ronckers CM, Zwinderman AH, Balm A, Hartley B, Van den Brekel M, Gupta S, Saeed P, Gajdosova E, Pieters BR, Gaze MN, Mandeville HC, Davila Fajardo R, Ch'ing Chang Y, Strackee SD, Dunaway D, Abela Ch, Mason C, Smeele LE, Chisholm JC, Levitt G, Kremer LC, Grootenhuis MA, Maurice-Stam H, Stiller CA, Hammond P, Caron HN, Merks JHM. Adverse events of local treatment in head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatment. Eur J Cancer. 2015; 51: 1424-34.

Huijskens SC, van Dijk IWEM, De Jong R, Visser J, Dávila Fajardo R, Ronckers CM, Janssens GORJ, Maduro JH, Rasch CRN, Alderliesten T, Bel A. Quantification of renal and diaphragmatic interfractional motion in pediatric image-guided radiation therapy: A multicenter study. Radiother Oncol. 2015; 117: 425-31.

Van Dijk IWEM, Van Os RM, Van de Kamer, JB, Franken NAP, Van der Pal HJH, Koning CCE, Caron HN, Kremer LC*, Ronckers CM*. The use of equivalent radiation dose in the evaluation of late effects after childhood cancer treatment. J Cancer Surviv. 2014; 8: 638-46.

Meulepas JM, Ronckers CM, Smets AM, Nievelstein RA, Jahnen A, Lee C, Kieft M, Laméris JS, Van Herk M, Greuter MJ, Jeukens CR, Van Straten M, Visser O, Van Leeuwen FE, Hauptmann M. Leukemia and brain tumors among children after radiation exposure from CT scans: design and methodological opportunities of the Dutch Pediatric CT Study. Eur J Epidemiol. 2014; 29: 293-301.

Van den Berg MH, Van Dulmen-den Broeder E, Overbeek A, Ronckers CM, Van Dorp W, Kremer LC, Van den Heuvel-Eibrink MM, Huizinga GA, Loonen JJ, Versluys AB, Bresters D, Lambalk CB, Kaspers GJL, Van Leeuwen FE. Fertility studies in female childhood cancer survivors: selecting appropriate comparison groups. Reprod Biomed Online. 2014; 29: 352-61.

Van Dijk IWEM, Cardous-Ubbink MC, Van der Pal HJH, Heinen RC, Van Leeuwen FE, Oldenburger F, Vn Os R, Ronckers CM, Schouten - van Meeteren AYN, Caron HN, Koning CCE, Kremer LCM. Dose-effect relationships for adverse events after cranial radiotherapy in long-term childhood cancer survivors. Int J Radiat Oncol Biol Phys. 2013; 85: 768-775.

Kovalchik SA, Ronckers CM, Veiga LH, Sigurdson AJ, Inskip PD, De Vathaire F, Sklar CA, Donaldson SS, Anderson H, Bhatti P, Hammond S, Leisenring WM, Mertens AC, Smith SA, Stovall M, Tucker MA, Weathers RE, Robison LL, Pfeiffer RM. Absolute risk of second primary thyroid cancer for 5-year survivors of a childhood cancer. J Clin Oncol. 2013; 31: 119-27.

Overbeek A, Van den Berg MH, Hukkelhoven CWPM, Kremer LC, Van den Heuvel-Eibrink MM, Tissing WJE, Loonen JJ, Versluys AB, Bresters D, Kaspers GJL, Lambalk CB, Van Leeuwen FE, Van Dulmen-den Broeder, and the DCOG LATER/VEVO Study Group. Validity of self-reported data on pregnancies: a comparison with data from a nationwide population-based registry. Hum Reprod. 2013; 28:819-27.

Van den Berg MH, Overbeek A, Kremer LC, van den Heuvel-Eibrink MM, Tissing WJE, Loonen JJ, Versluys AB, Bresters D, Kaspers GJL, Lambalk CB, Van Leeuwen FE, Van Dulmen-den Broeder, and the DCOG LATER-VEVO study group. A nationwide study on reproductive function, ovarian reserve, and risk of premature menopause in female survivors of childhood cancer: design and methodological challenges. BMC Cancer. 2012; 12: 363.

Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, Howe NL, Ronckers CM, Rajaraman P, Craft AW, Parker L, Berrington de Gonzalez A. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours, an historical cohort study. Lancet. 2012; 380: 499-505.

Veiga LHS, Bhatti P, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Weathers MS, Leisenring W, Mertens AC, Hammond S, Neglia JP, Meadows AT, Donaldson SS, Sklar CA, Friedman DL, Robison LL, Inskip PD. Chemotherapy and the risk of thyroid cancer after a childhood malignancy: an update from the Childhood Cancer Survivor study. Cancer Epidemiology Biomarkers Prevention. 2012; 21: 92-101.

Bhatti P, Veiga LHS, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Weathers MS, Leisenring W, Mertens AC, Hammond S, Friedman DL, Neglia JP, Meadows AT, Donaldson SS, Sklar CA, Robison LL, Inskip PD. Radiotherapy for childhood cancer and risk of thyroid cancer in a large cohort study: An update from the Childhood Cancer Survivor Study. Radiat Res. 2010; 174: 741-52.

Ronckers CM, Land CE, Miller JS, Stovall M, Lonstein JE, Doody MM. Cancer mortality among women frequently exposed to radiographic exams for spinal disorders. Radiat Res. 2010; 174: 83–90.

Ronckers CM, Doody MM, Lonstein JE, Stovall M, Land CE. Multiple diagnostic X-rays, spine deformities and risk of breast cancer. The U.S. Scoliosis Cohort Study. Cancer Epidemiology Biomarkers Prevention. 2008; 17: 605-13.

Bluhm EC, Ronckers CM, Hayashi RJ, Neglia JP, Mertens AC, Stovall M, Meadows AT, Mitby PA, Whitton JA, Hammond S, Barker JD, Donaldson SS, Robison LL, Inskip PD. Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood. 2008; 111: 4014-21.

Chodick G, Ronckers CM, Shalev V, Ron E. Excess lifetime mortality due to radiation exposure from pediatric computed tomography examinations. Isr Med Assoc J. 2007; 9: 584-7.

Chodik G, Ronckers CM, Ron E, Shalev V. The utilization of pediatric computed tomography in a large Israeli HMO. Pediatric Radiol. 2006; 36: 485-90.

Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Mertens AC, Liu Y, Hammond S, Land CE, Neglia JP, Meadows AT, Sklar CA, Robison LL, Inskip P. Thyroid cancer following pediatric malignancies: A detailed evaluation of radiation dose-response and its modifiers. Radiat Res. 2006; 166: 618-28.

Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, Ronckers CM, Friedman DL, Stovall M, Yasui Y, Meadows AT, Kadan-Lottick NS. Risk of a carcinoma as a subsequent primary neoplasm in survivors of childhood cancer: A report from the childhood cancer survivor study. J Clin Oncol. 2006; 24: 476-83.

Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, Berkow R, Sklar CA, Hammond S, Neglia JP, Meadows AT, Robison LL, Inskip PD. Second primary thyroid cancer after a first childhood malignancy: A report from the Childhood Cancer Survivor Study. Lancet. 2005; 365: 2014-23.

Ronckers CM, McCarron P, Ron E. Thyroid cancer and multiple primary tumors in the SEER cancer registries. Int J Cancer. 2005; 117: 281-88.

Zhang Y, Graubard BI, Klebanoff MA, Ronckers CM, Stanczyk FZ, Longnecker MP, McGlynn KA. Maternal hormone levels among populations at high and low risk of testicular germ cell cancer. Br J Cancer. 2005; 92: 1787-93.

Ronckers CM, Land CE, Hayes RB, Verduijn PG, van Leeuwen FE. Factors impacting questionnaire response in a Dutch retrospective cohort study. Ann Epidemiol. 2004; 14: 66-72.

Ronckers CM, Van Leeuwen FE, Hayes RB, Verduijn PG, Stovall M, Land CE. Cancer incidence after nasopharyngeal radium irradiation. Epidemiology. 2002; 13: 552-60.

Ronckers CM, Land CE, Hayes RB, Verduijn PG, Stovall M, Van Leeuwen FE. Late health effects of childhood nasopharyngeal radium irradiation: non-melanoma skin cancers, benign tumors and hormonal disorders. Pediatr Res. 2002; 52: 850-8.

Ronckers CM, Land CE, Verduijn PG, Hayes RB, Stovall M, Van Leeuwen FE. Cancer mortality after nasopharyngeal radium irradiation in the Netherlands: a cohort study. J Natl Cancer Inst. 2001; 13: 1021-7.

Van den Brandt PA, Dirx MJM, Ronckers CM, Van den Hoogen P, Goldbohm RA. Height. Weight, weight change, and postmenopausal breast cancer risk: the Netherlands Cohort Study. Cancer Causes Control. 1997; 8: 39-47.